PROSTATE CANCER (PC) The Prostate Cancer (PC) Program aims to advance scientific knowledge that will reduce the morbidity and mortality attributed to PC and lead to improvements in patients? quality of life. The PC Program has three primary aims: (1) Develop approaches for determining early stage PC risk, optimizing detection strategies, and deploying risk-based interventions; (2) Advance the molecular understanding of the androgen receptor signaling program to inform the rational design of therapeutic strategies for treating high-risk localized and metastatic PC; and (3) Evolve therapeutic approaches for the treatment of PCs directed toward inhibiting key oncogenic (intrinsic) drivers and modulating components of the tumor microenvironment. The PC Program has 42 members based at the University of Washington (UW) or Fred Hutch (FH), with clinical practice sites at the UW, Seattle Cancer Care Alliance (SCCA), and Veterans Administration (VA) Puget Sound Health Care System. Nine PC members have primary appointments at FH and 33 members at UW spanning 11 Departments and Divisions. Ten members joined this program since the last cycle. The current research portfolio of PC members is $11.6M (direct costs), of which $8.6M is peer-reviewed funding, including $2M from the NCI. A substantial component of the research funding is in the form of P50, P01, U54 and other collaborative grants. The Prostate Cancer program members published a total of 558 papers in the current grant period, of which 31% were intra-programmatic, 22% were inter-programmatic, and 56% had external co-authors. Eleven out of 12 Consortium Shared Resources were utilized by PC members in the course of their work. In addition to providing key shared resources, in particular Comparative Medicine, Genomics & Bioinformatics, and Research Pathology Shared Resources, the P30 CCSG supports this research program by providing administrative and logistical support for PC Program meetings; pilot funding for new research projects; and recruitment of new faculty.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125974
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
Shirts, Brian H; Konnick, Eric Q; Upham, Sarah et al. (2018) Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes. Am J Hum Genet 103:19-29
Kuzma, Jessica N; Hagman, Derek K; Cromer, Gail et al. (2018) Intra-individual variation in markers of intestinal permeability and adipose tissue inflammation in healthy normal weight to obese adults. Cancer Epidemiol Biomarkers Prev :
Suzuki, Aussie; Gupta, Amitabha; Long, Sarah K et al. (2018) A Kinesin-5, Cin8, Recruits Protein Phosphatase 1 to Kinetochores and Regulates Chromosome Segregation. Curr Biol 28:2697-2704.e3
Verboon, Jeffrey M; Decker, Jacob R; Nakamura, Mitsutoshi et al. (2018) Wash exhibits context-dependent phenotypes and, along with the WASH regulatory complex, regulates Drosophila oogenesis. J Cell Sci 131:
Thornblade, Lucas W; Mulligan, Michael S; Odem-Davis, Katherine et al. (2018) Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer. Ann Thorac Surg 106:1460-1467
Adrianse, Robin L; Smith, Kaleb; Gatbonton-Schwager, Tonibelle et al. (2018) Perturbed maintenance of transcriptional repression on the inactive X-chromosome in the mouse brain after Xist deletion. Epigenetics Chromatin 11:50
Walter, Roland B; Othus, Megan; Orlowski, Kaysey F et al. (2018) Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm. Haematologica 103:e106-e109
Lee, Dale; Swan, C Kaiulani; Suskind, David et al. (2018) Children with Crohn's Disease Frequently Consume Select Food Additives. Dig Dis Sci 63:2722-2728

Showing the most recent 10 out of 1267 publications